Standard Biotools Filter Stocks by Fundamentals
| LAB Stock | USD 0.98 0.04 4.26% |
| = | null |
Did You Try This?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Important Fundamentals
| Return On Equity TTM | -0.13 | ||||
| Return On Asset TTM | -0.0988 | ||||
| Profit Margin TTM | -0.88 | ||||
| Operating Margin TTM | -0.92 | ||||
| Current Valuation | 208.44 M | ||||
| Shares Outstanding | 390.37 M | ||||
| Shares Owned By Insiders | 1.50 % | ||||
| Shares Owned By Institutions | 76.30 % | ||||
| Number Of Shares Shorted | 8.48 M | ||||
| Price To Earnings TTM | -2.52 X | ||||
| Price To Book TTM | 0.86 X | ||||
| Price To Sales TTM | 4.28 X | ||||
| Revenue TTM | 85.33 M | ||||
| Gross Profit TTM | 42.54 M | ||||
| EBITDA TTM | -94.96 M | ||||
| Net Income TTM | -74.9 M | ||||
| Cash And Equivalents TTM | 81.31 M | ||||
| Cash Per Share TTM | 2.68 X | ||||
| Total Debt TTM | 30.83 M | ||||
| Debt To Equity TTM | 0.38 % | ||||
| Current Ratio TTM | 5.87 X | ||||
| Book Value Per Share TTM | 1.10 X | ||||
| Cash Flow From Operations TTM | -74.35 M | ||||
| Short Ratio TTM | 3.20 X | ||||
| Earnings Per Share | -0.15 X | ||||
| Price To Earnings To Growth | 0.31 X | ||||
| Target Price | 1.55 | ||||
| Number Of Employees | 385 | ||||
| Trailing Beta | 1.31 | ||||
| Market Capitalization TTM | 364.99 M | ||||
| Total Asset TTM | 567.75 M | ||||
| Retained Earnings TTM | -1.26 B | ||||
| Working Capital TTM | 345.96 M | ||||
| Net Asset | 567.75 M |
Financial Metrics, Fundamentals & Methodology
Fundamental metrics for Standard Biotools are informative when they are tied back to operating resilience and capital allocation. The company is currently operating at a loss. Overall market capitalization tier is small-cap. Standard Biotools financial statements report revenue of 85.33 million, EPS loss of 0.15, negative operating margin of 92.14%, current ratio of 5.87 as of the latest reporting period.
Standard Biotools metrics draw on periodic company reporting and market reference feeds, standardized for cross-period comparison. Reported income, balance-sheet, and cash-flow fields adhere to GAAP or IFRS presentation rules.
Editorial review and methodology oversight provided by: Gabriel Shpitalnik, Member of Macroaxis Editorial Board